The collagen-modifying enzyme GLT25D1 is a prognostic indicator related to immunosuppression and malignant phenotypes in hepatocellular carcinoma
Our results showed that GLT25D1 could be a carcinogenic indicator reflecting poor prognosis and might serve as a potential risk biomarker for HCC patients.
Authors
- Mengliu Yang
- Gangyi Yang (ORCID: https://orcid.org/0000-0002-6458-6747)
- Ling Li (ORCID: https://orcid.org/0000-0003-3923-5184)
- Hao Wang (ORCID: https://orcid.org/0000-0001-7661-3688)
- Ke Li (ORCID: https://orcid.org/0000-0002-2933-1773)
- Hongmin Zhang (ORCID: https://orcid.org/0000-0002-7514-3087)
- Huan Han (ORCID: https://orcid.org/0000-0003-0537-3191)
- Sheng Qiu (ORCID: https://orcid.org/0009-0000-0983-9206)
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1186/s12935-025-03715-z
- Citations
- 1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation